NERX BIOSCIENCES, INC.
| 351 W 10TH ST, STE 510
INDIANAPOLIS, IN, 46202-4118
|Firm CFO (or equivalent):|
|POC Contracting Officer (or equivalent)|
|SBC Control ID:||SBC_000391004|
DESCRIPTION (provided by applicant): Epithelial ovarian cancer (EOC) is uniformly fatal once resistance to platinum based therapy (Pt) is observed. Innate resistance is observed in approximately 25% o ...STTR Phase I 2012 Department of Health and Human Services
DESCRIPTION (provided by applicant): Platinum based agents (Pt) are the most commonly prescribed chemotherapeutics used in the treatment of solid tumors and are part of the curative treatment regimen ...SBIR Phase I 2012 Department of Health and Human Services